Table 2.
Baseline infant medication use and concomitant medical problems.
| Participant | Medications | Concomitant medical problem(s) |
|---|---|---|
| tAN 1 | Vitamin D | Hypoglycemia, resolved |
| tAN 2 | Vitamin D Dolutegravir (5 mg) Lamivudine (10 mg/ml) Nystatin Sulfamethoxazole-Trimethoprim Zidovudine (10 mg/ml) | Early Latent Syphilis Herpes simplex virus infection Hepatitis C Gonorrhea Chlamydia |
| tAN 3 | Vitamin D | Hyperbilirubinemia Abnormal x-ray of humerus Hyperosmolality/Hypernatremia Respiratory distress syndrome requiring initial CPAP |
| tAN 4 | Ativan (0.05 mg/kg) | Meconium aspiration below vocal cords resolved |
| tAN 5 | Penicillin Vitamin D | Hepatitis B (maternal) Hepatitis C (maternal) Ankyloglossia Syphilis (maternal) Tethered labial frenulum |
| tAN 6 | Clonidine (7 mcg- >10 mcg) Simethicone (40 mg/0.6ml oral drop) | Tobacco use (maternal) |
| tAN 7 | Gentamicin Ampicillin Ativan given once | Respiratory distress syndrome, resolved |
| tAN 8 | Vitamin D Acetylcysteine Acyclovir Ampicillin Gentamicin | Hyperbilirubinemia Failed newborn hearing screen1 Hepatitis C (maternal) Hepatitis B (maternal) Lactobezoar |
1Failed routine newborn hearing screen, 8 days before starting tAN treatment. The infant had a formal hearing screen as an outpatient 9 days after discharge and passed the hearing screen at that time.